Mononuclear cells from the blood of healthy normal humans were kept in cultures under nonstimulating conditions for 16 [14C]thymidi'ne to 0.2 ml of cell supension in microtiter plates which were harvested and assayed for radioactivity 12-16 hr later, according to standard procedures. Cells were washed two or three times in medium containing 5% fetal calf serum And 15 mM Na azide and then were incubated with 1:25 diluted fluorescein isothiocyanate (FITC)-labeled specific rabbit anti-human [B2-m antiserum (Dakopatts, code F112, Dakopatts, Copenhagen) or with a 1:8 dilution of a nonlabeled broadly reacting anti-VJLA antiserum including the specificity Bw4. The serum "Buffo" from the International Serum Bank in Torino was kindly provided by J. Stocker (Basel). After a 45-min incubation, the cells were processed for quantitative immunofluorescence in the fluorescence-activated cell sorter (FACS II, Becton-Dickinson) or were washed three times and incubated with the second layer, which was a 1:50 dilution of FITC-conjugated goat IgG anti-human Fc antibodies (a kind gift of L. Forni, Basel), for a further 30 min.
croglobulin on the cultured cells were determined by quantitative immunofluorescence (fluorescence-activated cell sorter) and by the capacity of cells to absorb out cytotoxic antibodies against the relevant antigens. Interferons of different origin and purities enhanced the expression of HLA antigens and #2-microglobulins; whereas membrane immunoglobulins and antigens recognized by antiserum raised against human brain and T cells were the same on interferon-treated and control cells. Similar interferon effects were observed on an Epstein-Barr virus-negative Burkitt lymphoma cell line. The enhanced expression of histocompatibility antigen subsequent to interferon treatment was observed on B-and T-enriched lymphocyte populations and was found to be dose dependent with the optimum with "physiological" concentrations of interferon. Pretreatment of lymphocytes with interferon for 2 hr was found to be as effective as having interferon present during the total culture period. The interferon-induced enhancement of antigen expression on cells was dependent on active protein syntheSiS.
The biological effects of interferon (IF) may be divided into two categories: antiviral and nonviral. Among the nonviral effects of IF, the effects on lymphocytes and their functions are prominent. These include inhibition of DNA synthesis in stimulated lymphocytes (1) , inhibition of antibody responses in culture (2) , inhibition of multiplication of lymphocytes transferred into x-irradiated recipients (3) , enhancement of cytotoxicity of sensitized mouse spleen lymphocytes (4) , and augmentation of killer cell generation in vitro during mixed lymphocyte culture (5, 6) . Furthermore, enhanced expression of histocompatibility antigens on mouse lymphoid cells treated with IF was shown recently (7) .
Lymphocytes from the blood of healthy humans and a human B-cell line have been studied in the present series of experiments subsequent to treatment with highly purified human IF preparations. It Proc. Natl. Acad. Sci. USA 75 (1978) code F2190) and processed for the FACS, as described below. Separation of B and T cells was performed by rosetting procedures as described (9) . Adherent and phagocytic cells were removed by using carbonyl-iron and a magnet. Cells to be analyzed in the FACS were washed three times and suspended in medium containing 5% fetal calf serum and 15 mM Na azide at a concentration of approximately 1 X 106 cells per ml. Cells (20,000-100,000) of each sample were analyzed at 40C for green fluorescence, and a histogram showing the number of stained cells against the intensity of fluorescence was recorded. The scatter signals given by the passed cells was likewise recorded. Controls analyzed included nonstained cell suspensions to correct for background fluorescence and lymphocytes stained as for detection of HLA antigens but without the first layer (cells labeled in this way gave essentially no fluorescence above "machine" background). The mean fluorescence intensity per cell was computed by using the formula Di c/ i in which i is the channel number and c is the number of cells appearing in the channel. When the same suspension of labeled cells was assessed twice, less than a 2% difference in the computed mean fluorescence intensity was found. Single determinations were therefore mostly performed and the data in the tables appear without SEM.
Cytotoxic Test and Absorptions. Freshly isolated lymphocytes (2 X 106/ml) were incubated for 45 min at 370C in equal volumes of antibody dilution in medium and fresh rabbit serum. Cell viability was assessed by trypan blue exclusion. Absorption was performed on 100-,gl quantities of antibody dilutions with cell suspensions of more than 90% viability. After incubation at 00C for 1 hr with frequent shaking, cells were pelleted by centrifugation and the supernatant was pipetted off.
Cell Line. The lymphoblastoid cell line BJAB, which is derived from a Burkitt-lymphoma patient but is Epstein-Barr virus-negative, was obtained from J. Zeuthen (Institute of Human Genetics, University of Aarhus). The cells were grown in RPMI medium supplemented with 10% fetal calf serum.
Production of IF. Human leukocyte IF was obtained from normal buffy coats stimulated by Sendai virus, according to the method of Cantell et al. (10) . The crude IF preparation was concentrated with KSCN and partially purified by acidic methanol precipitation and subsequent precipitation by pH change. The titer of this partially purified IF (PIF) was 5 X 106 IF units/ml (specific activity, 1 X 106 IF units/mg). These preparations were a kind gift from K. Osther (Copenhagen). All IF titers are expressed in 69/19B units.
Highly purified IF was prepared from PIF by means of gel filtration in urea, followed by affinity chromatography using highly absorbed anti-IF antibodies (11) . The specific activity of the purified material was 2 X 108 IF units/mg of protein.
Mock PIF (also provided by K. Osther) was prepared by precipitation procedures as described for PIF. The starting material consisted of supernatant from buffy coats that had received only a minute amount of egg allantoic fluid. Highly purified mock IF was prepared by subjecting nonviral-induced supernatants to the purification protocol as described above. Mock preparations were compared with the IF preparations at similar protein concentrations.
Crude fibroblast IF with a specific activity of 105 IF units/mg of protein was provided by R. Hamilton (The Upjohn Co., Kalamazoo, MI). RESULTS The binding of rabbit anti-f2-m and of anti HLA-Bw4 antibodies to mononuclear cells from peripheral blood was investigated with the FACS. The donors to be used for the anti-HLA testing were selected beforehand to be Bw4 positive. , including studies with cells from 10 donors assayed one to eight times with anti-32-m antibodies as well as from the 2 donors also tested by using anti-HLA-Bw4. The curve shift could be registered by a change in the position of the peak of the fluorescent cell intensity as well as by an increase in the computed mean intensity per cell. The relative increase in mean fluorescence intensity with anti-f2-m antibodies and nonseparated blood lymphocytes subjected to a standard dose (500 IF units/ml) for 16 hr varied from 21 to 48%, depending on the donor (Fig. 2) . In addition, the same relative fluorescence in- Fig. 4 gives the scatter and fluorescence profiles for such an experiment. #2-m was increased, whereas IgM was unchanged. Analysis of the number of cells at different stages in the cell cycle was performed by ethidium bromide nuclear labeling and analysis in the FACS, and it was found that there were no differences in distribution when IF-treated and untreated cells were compared.
To determine whether the effects of IF observed are dependent on metabolically active cells and require intact protein synthesis, lymphocytes were cultured also at 200C and 40C with and without IF; in addition, puromycin was added at varying concentrations to cells cultured at 370C. The temperature ex- (7) and also in svo when injected into young mice (16 
